Hyalex welcomes executive team member, Chris Cain, serving as Vice President of Clinical and Regulatory Affairs. Chris joins the Hyalex team with an impressive background in leading numerous clinical trials of implanted medical devices and taking innovative technologies through US PMA and international regulatory approvals.  Chris provides the experience necessary to bring the HYALEX® Cartilage System into the clinic, both in the U.S. and in other key markets around the world.

Chris most recently served as VP of Clinical and Regulatory Affairs at Devoro Medical, Inc., up to its acquisition by Boston Scientific. Prior to that, he held leadership roles in clinical and regulatory affairs at Conformal Medical, Corindus Vascular Robotics, ZOLL Medical Corporation, Edwards Lifesciences, and Pavad Medical. Chris has a unique and invaluable background, initially working as a registered nurse and serving as an Army aviator.

“I’m thrilled to be joining the Hyalex team,” says Chris. “The HYALEX Cartilage System has the potential to address a large and unmet need in the area of knee lesion repair. I’m eager to help the company advance into the clinic and navigate regulatory processes to achieve appropriate clearances and approvals to enter global markets.”

About Hyalex Orthopaedics

Hyalex is a privately-held medical device company headquartered in Lexington, MA, developing transformational synthetic cartilage technology and implant systems for diseased and damaged joints. HYALEX® Cartilage is protected by more than 17 patents and trademarks worldwide.

The HYALEX® Cartilage System is under development and not available for clinical use.

For more information: www.hyalex.com


SOURCE Hyalex Orthopaedics, Inc.